Shares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

RELIEVES DRYNESS: Gentle mist helps to moisturize and relieve dryness in the nose CLEARS CONGESTION: Helps to alleviate congestion and stuffy noses, and flushes irritants from the nasal passage ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...

H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from the ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...

SO I WOULD REALLY EMPHASIZE THE NASAL STEROID SPRAYS. FLONASE OR NASACORT ARE EXCELLENT OVER-THE-COUNTER OPTIONS FOR PATIENTS. BE CAREFUL WHEN YOU USE THEM. YOU REALLY DON’T WANT TO IRRITATE THE ...

CRL focused on CMC; no clinical issues relating to etripamil raised$69.7M in cash, cash equivalents and short-term investments as of December 31, ...

Cyrano Therapeutics, a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, and Resyca, a leading innovator in soft mist inhaler and soft nasal spray ...

Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results ... administration 70-mg repeat-dose regimen, of etripamil nasal spray, outside of the medically supervised setting, similar ...